Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Cyclosporine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Cyclosporine | hsa00061 | Fatty acid biosynthesis | 4.07E-02 | 1 | P33121 | ACSL1 | More | | Cyclosporine | hsa00190 | Oxidative phosphorylation | 1.48E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | | Cyclosporine | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Cyclosporine | hsa00512 | Mucin type O-glycan biosynthesis | 1.42E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Cyclosporine | hsa00565 | Ether lipid metabolism | 4.26E-02 | 1 | Q8N661 | TMEM86B | More | | Cyclosporine | hsa00590 | Arachidonic acid metabolism | 3.13E-03 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Cyclosporine | hsa00591 | Linoleic acid metabolism | 1.63E-03 | 1 | P11712 | CYP2C9 | More | | Cyclosporine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.52E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Cyclosporine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Cyclosporine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Cyclosporine | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Cyclosporine | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Cyclosporine | hsa01100 | Metabolic pathways | 1.25E-02 | 11 | O14521, Q13370, P11712, P24666, P23743, O60701, P33121, Q9NY28, P09960, Q9Y2B2, Q16718 | SDHD, PDE3B, CYP2C9, ACP1, DGKA, UGDH, ACSL1, GALNT8, LTA4H, PIGL, NDUFA5 | More | | Cyclosporine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.60E-02 | 2 | P17252, Q9NRA1 | PRKCA, PDGFC | More | | Cyclosporine | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Cyclosporine | hsa02010 | ABC transporters | 4.26E-02 | 1 | Q8IZY2 | ABCA7 | More | | Cyclosporine | hsa03013 | RNA transport | 7.27E-03 | 12 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, Q14240, Q9Y6A5, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, EIF4A2, TACC3, FXR1 | More | | Cyclosporine | hsa03022 | Basal transcription factors | 2.17E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Cyclosporine | hsa03040 | Spliceosome | 1.38E-08 | 12 | Q14562, O43143, O60508, P17844, P08579, P26368, Q15365, Q07955, Q01130, Q13243, P11142, O43447 | DHX8, DHX15, CDC40, DDX5, SNRPB2, U2AF2, PCBP1, SFRS1, SFRS2, SFRS5, HSPA8, PPIH | More | | Cyclosporine | hsa03060 | Protein export | 4.22E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Cyclosporine | hsa03320 | PPAR signaling pathway | 2.93E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Cyclosporine | hsa03430 | Mismatch repair | 4.50E-02 | 2 | P43246, Q04837 | MSH2, SSBP1 | More | | Cyclosporine | hsa03440 | Homologous recombination | 4.50E-02 | 2 | Q9Y620, Q04837 | RAD54B, SSBP1 | More | | Cyclosporine | hsa04014 | Ras signaling pathway | 6.63E-06 | 13 | P31751, P42338, P20827, Q9NRA1, P49767, Q13009, P17252, Q15311, Q14644, P0DP23, P62873, P63218, P19174 | AKT2, PIK3CB, EFNA1, PDGFC, VEGFC, TIAM1, PRKCA, RALBP1, RASA3, CALM1, GNB1, GNG5, PLCG1 | More | | Cyclosporine | hsa04015 | Rap1 signaling pathway | 1.07E-04 | 12 | P20827, Q9NRA1, P49767, P25116, Q13009, Q08828, P51828, P31751, P0DP23, P08514, P17252, P19174 | EFNA1, PDGFC, VEGFC, F2R, TIAM1, ADCY1, ADCY7, AKT2, CALM1, ITGA2B, PRKCA, PLCG1 | More | | Cyclosporine | hsa04020 | Calcium signaling pathway | 5.19E-09 | 14 | P27987, Q08828, Q13557, P17252, O15399, P19174, P25116, P61073, P0DP23, P51828, P20020, P23634, Q9NRA1, P49767 | ITPKB, ADCY1, CAMK2D, PRKCA, GRIN2D, PLCG1, F2R, CXCR4, CALM1, ADCY7, ATP2B1, ATP2B4, PDGFC, VEGFC | More | | Cyclosporine | hsa04022 | cGMP-PKG signaling pathway | 1.28E-02 | 4 | Q14814, P21796, P0DP23, P01042 | MEF2D, VDAC1, CALM1, KNG1 | More | | Cyclosporine | hsa04024 | cAMP signaling pathway | 5.93E-05 | 12 | Q08828, P51828, P42338, P31751, P0DP23, P20020, P23634, Q13557, Q13370, O15399, P25116, Q13009 | ADCY1, ADCY7, PIK3CB, AKT2, CALM1, ATP2B1, ATP2B4, CAMK2D, PDE3B, GRIN2D, F2R, TIAM1 | More | | Cyclosporine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.57E-03 | 8 | Q8NHW4, P09341, P19875, P25024, P25025, P61073, Q13651, P14784 | CCL4L2, CXCL1, CXCL2, CXCR1, CXCR2, CXCR4, IL10RA, IL2RB | More | | Cyclosporine | hsa04062 | Chemokine signaling pathway | 1.29E-03 | 17 | P51684, P25024, P25025, P09341, P19875, Q8NHW4, P42338, P19174, P62873, P63218, P50151, Q08828, P51828, Q13009, P14598, P42224, P31751 | CCR6, CXCR1, CXCR2, CXCL1, CXCL2, CCL4L2, PIK3CB, PLCG1, GNB1, GNG5, GNG10, ADCY1, ADCY7, TIAM1, NCF1, STAT1, AKT2 | More | | Cyclosporine | hsa04064 | NF-kappa B signaling pathway | 6.49E-07 | 17 | P10415, Q13489, P51617, P14778, P01584, P29965, P19174, Q04759, P67870, P06239, P63279, O75293, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, IRAK1, IL1R1, IL1B, CD40LG, PLCG1, PRKCQ, CSNK2B, LCK, UBE2I, GADD45B, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Cyclosporine | hsa04068 | FoxO signaling pathway | 4.30E-02 | 4 | P42338, P30279, O75293, Q13485 | PIK3CB, CCND2, GADD45B, SMAD4 | More | | Cyclosporine | hsa04070 | Phosphatidylinositol signaling system | 5.66E-04 | 6 | P19174, P0DP23, P23743, P48426, P27987, P17252 | PLCG1, CALM1, DGKA, PIP4K2A, ITPKB, PRKCA | More | | Cyclosporine | hsa04071 | Sphingolipid signaling pathway | 5.25E-04 | 9 | P17252, Q9H228, P01375, Q13510, Q13362, Q9BX95, P10415, Q9UQC2, P01042 | PRKCA, EDG8, TNF, ASAH1, PPP2R5C, SGPP1, BCL2, GAB2, KNG1 | More | | Cyclosporine | hsa04072 | Phospholipase D signaling pathway | 7.28E-06 | 14 | P31751, P42338, P43657, P25116, P25024, P25025, P19174, P17252, Q15438, Q08828, P51828, P23743, Q9NRA1, P00734 | AKT2, PIK3CB, P2RY5, F2R, CXCR1, CXCR2, PLCG1, PRKCA, PSCD1, ADCY1, ADCY7, DGKA, PDGFC, F2 | More | | Cyclosporine | hsa04114 | Oocyte meiosis | 2.44E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Cyclosporine | hsa04140 | Autophagy - animal | 2.58E-02 | 7 | P31751, Q7L523, Q96RR4, O75460, P10415, Q96GC9, Q8TEV9 | AKT2, RRAGA, CAMKK2, ERN1, BCL2, TMEM49, SMCR8 | More | | Cyclosporine | hsa04144 | Endocytosis | 8.99E-03 | 12 | P11142, Q9H444, O43633, O75351, Q9NZZ3, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Cyclosporine | hsa04150 | mTOR signaling pathway | 4.20E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Cyclosporine | hsa04151 | PI3K-Akt signaling pathway | 5.22E-04 | 18 | P25116, O43521, P27348, P20827, Q9NRA1, P49767, Q13362, P08238, P62873, P08514, P16144, P14784, P23458, P01568, P18848, P10415, P17252, Q6ZUJ8 | F2R, BCL2L11, YWHAQ, EFNA1, PDGFC, VEGFC, PPP2R5C, HSP90AB1, GNB1, ITGA2B, ITGB4, IL2RB, JAK1, IFNA21, ATF4, BCL2, PRKCA, PIK3AP1 | More | | Cyclosporine | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Cyclosporine | hsa04213 | Longevity regulating pathway - multiple species | 2.34E-03 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Cyclosporine | hsa04217 | Necroptosis | 3.39E-08 | 15 | P01568, P23458, Q13489, Q9NQC7, P42224, P08238, P01584, P0C0S5, Q6FI13, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351 | IFNA21, JAK1, BIRC3, CYLD, STAT1, HSP90AB1, IL1B, H2AFZ, H2AC18; H2AC19, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B | More | | Cyclosporine | hsa04218 | Cellular senescence | 7.85E-03 | 5 | P42338, P30279, O75293, P0DP23, P21796 | PIK3CB, CCND2, GADD45B, CALM1, VDAC1 | More | | Cyclosporine | hsa04260 | Cardiac muscle contraction | 4.49E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | | Cyclosporine | hsa04261 | Adrenergic signaling in cardiomyocytes | 5.62E-07 | 12 | P09493, Q08828, P51828, P31751, P18848, Q13362, P0DP23, Q13557, P17252, P10415, P20020, P23634 | TPM1, ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2, ATP2B1, ATP2B4 | More | | Cyclosporine | hsa04340 | Hedgehog signaling pathway | 3.15E-03 | 4 | P49841, P22694, O43791, P30279 | GSK3B, PRKACB, SPOP, CCND2 | More | | Cyclosporine | hsa04360 | Axon guidance | 8.44E-04 | 8 | P61073, P16333, P20827, O95631, P17252, Q13557, P23528, P19174 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, CFL1, PLCG1 | More | | Cyclosporine | hsa04370 | VEGF signaling pathway | 1.66E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Cyclosporine | hsa04371 | Apelin signaling pathway | 1.70E-03 | 9 | P62873, P63218, P31751, Q08828, P51828, Q13370, Q14814, Q13485, P0DP23 | GNB1, GNG5, AKT2, ADCY1, ADCY7, PDE3B, MEF2D, SMAD4, CALM1 | More | | Cyclosporine | hsa04380 | Osteoclast differentiation | 4.18E-02 | 7 | Q9NQC7, Q9UQC2, P23458, P42224, P01584, Q15080, P14598 | CYLD, GAB2, JAK1, STAT1, IL1B, NCF4, NCF1 | More | | Cyclosporine | hsa04510 | Focal adhesion | 1.89E-03 | 9 | P16144, P08514, O75369, Q15942, P17252, Q13489, P10415, Q9NRA1, P49767 | ITGB4, ITGA2B, FLNB, ZYX, PRKCA, BIRC3, BCL2, PDGFC, VEGFC | More | | Cyclosporine | hsa04512 | ECM-receptor interaction | 3.19E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Cyclosporine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Cyclosporine | hsa04540 | Gap junction | 1.11E-03 | 6 | P17252, Q13509, P68371, Q08828, P51828, Q9NRA1 | PRKCA, TUBB3, TUBB2C, ADCY1, ADCY7, PDGFC | More | | Cyclosporine | hsa04610 | Complement and coagulation cascades | 1.72E-03 | 1 | P0C0L4 | C4A | More | | Cyclosporine | hsa04611 | Platelet activation | 7.90E-03 | 3 | P25116, P08514, P07359 | F2R, ITGA2B, GP1BA | More | | Cyclosporine | hsa04613 | Neutrophil extracellular trap formation | 1.12E-03 | 7 | P17252, Q93077, P62807, O60814, P68431, P08514, P07359 | PRKCA, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ITGA2B, GP1BA | More | | Cyclosporine | hsa04620 | Toll-like receptor signaling pathway | 1.33E-02 | 5 | P51617, P01568, P31751, P42224, Q8NHW4 | IRAK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Cyclosporine | hsa04621 | NOD-like receptor signaling pathway | 3.16E-02 | 9 | P01584, P08238, P23458, P42224, P01568, Q9H3M7, Q13489, P43490, P10415 | IL1B, HSP90AB1, JAK1, STAT1, IFNA21, TXNIP, BIRC3, PBEF1, BCL2 | More | | Cyclosporine | hsa04623 | Cytosolic DNA-sensing pathway | 1.55E-03 | 3 | P01584, P01568, Q8NHW4 | IL1B, IFNA21, CCL4L2 | More | | Cyclosporine | hsa04630 | JAK-STAT signaling pathway | 1.16E-02 | 8 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, IFNA21 | More | | Cyclosporine | hsa04640 | Hematopoietic cell lineage | 1.56E-03 | 10 | P07359, P08514, P14778, P27930, P11215, P25063, P07766, P01732, P09564, P04141 | GP1BA, ITGA2B, IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7, CSF2 | More | | Cyclosporine | hsa04650 | Natural killer cell mediated cytotoxicity | 6.98E-06 | 13 | P16298, P50591, P19174, P06239, O60880, P20963, P42338, Q02750, Q13241, P48551, P26718, O14931, Q07444 | PPP3CB, TNFSF10, PLCG1, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, IFNAR2, KLRK1, NCR3, KLRC3 | More | | Cyclosporine | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Cyclosporine | hsa04658 | Th1 and Th2 cell differentiation | 2.21E-04 | 8 | Q04759, P07766, P20963, P19174, P06239, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, TBX21, IL2RB, RUNX3 | More | | Cyclosporine | hsa04659 | Th17 cell differentiation | 1.25E-03 | 8 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, CD3E, CD247 | More | | Cyclosporine | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | | Cyclosporine | hsa04662 | B cell receptor signaling pathway | 4.24E-02 | 2 | P16298, Q02750 | PPP3CB, MAP2K1 | More | | Cyclosporine | hsa04664 | Fc epsilon RI signaling pathway | 2.60E-02 | 2 | P04141, P17252 | CSF2, PRKCA | More | | Cyclosporine | hsa04666 | Fc gamma R-mediated phagocytosis | 2.78E-02 | 6 | P08575, P19174, P23528, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, CFL1, GAB2, NCF1, PRKCA | More | | Cyclosporine | hsa04713 | Circadian entrainment | 8.01E-07 | 8 | O15399, P0DP23, Q13557, P17252, P62873, P63218, Q08828, P51828 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, GNG5, ADCY1, ADCY7 | More | | Cyclosporine | hsa04714 | Thermogenesis | 1.99E-02 | 3 | P33121, Q16718, O14521 | ACSL1, NDUFA5, SDHD | More | | Cyclosporine | hsa04720 | Long-term potentiation | 2.13E-04 | 9 | P17252, Q13557, P16298, P0DP23, P51812, P18848, O15399, Q08828, Q02750 | PRKCA, CAMK2D, PPP3CB, CALM1, RPS6KA3, ATF4, GRIN2D, ADCY1, MAP2K1 | More | | Cyclosporine | hsa04723 | Retrograde endocannabinoid signaling | 3.83E-02 | 2 | P17252, P62873 | PRKCA, GNB1 | More | | Cyclosporine | hsa04724 | Glutamatergic synapse | 7.37E-05 | 8 | O15399, Q08828, P51828, P17252, P62873, P63218, P15104, Q9NSB8 | GRIN2D, ADCY1, ADCY7, PRKCA, GNB1, GNG5, GLUL, HOMER2 | More | | Cyclosporine | hsa04725 | Cholinergic synapse | 6.48E-05 | 8 | Q08828, P51828, P17252, P62873, P18848, Q13557, P31751, P10415 | ADCY1, ADCY7, PRKCA, GNB1, ATF4, CAMK2D, AKT2, BCL2 | More | | Cyclosporine | hsa04726 | Serotonergic synapse | 2.87E-04 | 5 | P17252, P31645, P62873, P11712, P18054 | PRKCA, SLC6A4, GNB1, CYP2C9, ALOX12 | More | | Cyclosporine | hsa04727 | GABAergic synapse | 3.36E-03 | 5 | Q08828, P51828, P62873, P46459, P17252 | ADCY1, ADCY7, GNB1, NSF, PRKCA | More | | Cyclosporine | hsa04740 | Olfactory transduction | 2.61E-02 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Cyclosporine | hsa04744 | Phototransduction | 1.30E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Cyclosporine | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.64E-08 | 13 | P14778, P01584, P18054, Q08828, P51828, Q13557, P19174, P42338, P17252, P24723, Q04759, P0DP23, P01042 | IL1R1, IL1B, ALOX12, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCA, PRKCH, PRKCQ, CALM1, KNG1 | More | | Cyclosporine | hsa04810 | Regulation of actin cytoskeleton | 2.06E-02 | 3 | P08514, Q9NRA1, P25116 | ITGA2B, PDGFC, F2R | More | | Cyclosporine | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Cyclosporine | hsa04911 | Insulin secretion | 3.47E-02 | 4 | Q08828, P17252, P18848, Q13557 | ADCY1, PRKCA, ATF4, CAMK2D | More | | Cyclosporine | hsa04912 | GnRH signaling pathway | 2.85E-02 | 5 | P17252, Q08828, P18848, Q13557, P0DP23 | PRKCA, ADCY1, ATF4, CAMK2D, CALM1 | More | | Cyclosporine | hsa04914 | Progesterone-mediated oocyte maturation | 1.13E-03 | 10 | Q17RY0, Q08828, P51828, P31751, Q13370, Q9UJX4, Q9Y6D9, P08238, P51812, Q02750 | CPEB4, ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, MAD1L1, HSP90AB1, RPS6KA3, MAP2K1 | More | | Cyclosporine | hsa04915 | Estrogen signaling pathway | 3.51E-04 | 10 | P18848, Q08828, P51828, P42338, P31751, P08238, P11142, P0DP23, Q15788, P10415 | ATF4, ADCY1, ADCY7, PIK3CB, AKT2, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Cyclosporine | hsa04918 | Thyroid hormone synthesis | 1.14E-02 | 2 | P17252, P27824 | PRKCA, CANX | More | | Cyclosporine | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Cyclosporine | hsa04923 | Regulation of lipolysis in adipocytes | 1.20E-03 | 7 | Q08828, P51828, P07550, Q13370, P42338, Q9Y4H2, P31751 | ADCY1, ADCY7, ADRB2, PDE3B, PIK3CB, IRS2, AKT2 | More | | Cyclosporine | hsa04925 | Aldosterone synthesis and secretion | 6.45E-04 | 7 | P18848, Q08828, P51828, P0DP23, P17252, Q13557, P23634 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK2D, ATP2B4 | More | | Cyclosporine | hsa04926 | Relaxin signaling pathway | 1.14E-02 | 3 | P62873, P49767, P17252 | GNB1, VEGFC, PRKCA | More | | Cyclosporine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Cyclosporine | hsa04932 | Non-alcoholic fatty liver disease | 1.24E-02 | 6 | O43521, O75460, P01584, P13073, P12074, O15239 | BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFA1 | More | | Cyclosporine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.04E-06 | 8 | Q13485, P01584, P42224, P10415, P31751, P49767, P17252, P19174 | SMAD4, IL1B, STAT1, BCL2, AKT2, VEGFC, PRKCA, PLCG1 | More | | Cyclosporine | hsa04935 | Growth hormone synthesis, secretion and action | 3.93E-02 | 6 | P19174, Q08828, P51828, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, PRKCA, AKT2, STAT1 | More | | Cyclosporine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.48E-02 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | | Cyclosporine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.26E-02 | 1 | P00918 | CA2 | More | | Cyclosporine | hsa04966 | Collecting duct acid secretion | 4.26E-02 | 1 | P00918 | CA2 | More | | Cyclosporine | hsa04970 | Salivary secretion | 2.39E-04 | 6 | Q08828, P51828, P20020, P23634, P17252, P0DP23 | ADCY1, ADCY7, ATP2B1, ATP2B4, PRKCA, CALM1 | More | | Cyclosporine | hsa04972 | Pancreatic secretion | 1.16E-04 | 6 | P20020, P23634, P17252, Q08828, P51828, P62491 | ATP2B1, ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Cyclosporine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Cyclosporine | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Cyclosporine | hsa05010 | Alzheimer disease | 2.21E-02 | 10 | O15239, P13073, P12074, Q00535, O75460, P0DP23, P01584, O95197, P67870, P28070 | NDUFA1, COX4I1, COX6A1, CDK5, ERN1, CALM1, IL1B, RTN3, CSNK2B, PSMB4 | More | | Cyclosporine | hsa05016 | Huntington disease | 2.93E-02 | 4 | Q16718, O14521, O00268, Q13561 | NDUFA5, SDHD, TAF4, DCTN2 | More | | Cyclosporine | hsa05017 | Spinocerebellar ataxia | 8.81E-04 | 9 | P17252, O75460, Q8TB72, O15399, P42338, P31751, P28070, O00232, P21796 | PRKCA, ERN1, PUM2, GRIN2D, PIK3CB, AKT2, PSMB4, PSMD12, VDAC1 | More | | Cyclosporine | hsa05020 | Prion disease | 3.80E-02 | 4 | P11142, O15399, P21796, P42338 | HSPA8, GRIN2D, VDAC1, PIK3CB | More | | Cyclosporine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.91E-02 | 5 | Q16718, O14521, Q13561, P17252, Q08752 | NDUFA5, SDHD, DCTN2, PRKCA, PPID | More | | Cyclosporine | hsa05031 | Amphetamine addiction | 2.23E-03 | 6 | O15399, P0DP23, Q13557, P18848, P17252, Q13547 | GRIN2D, CALM1, CAMK2D, ATF4, PRKCA, HDAC1 | More | | Cyclosporine | hsa05032 | Morphine addiction | 7.65E-03 | 5 | Q08828, P51828, P62873, Q13370, P17252 | ADCY1, ADCY7, GNB1, PDE3B, PRKCA | More | | Cyclosporine | hsa05034 | Alcoholism | 3.99E-04 | 8 | O15399, Q13547, P0DP23, P63218, Q93077, P62807, O60814, P68431 | GRIN2D, HDAC1, CALM1, GNG5, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Cyclosporine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Cyclosporine | hsa05130 | Pathogenic Escherichia coli infection | 3.65E-02 | 3 | Q14247, P68371, P25116 | CTTN, TUBB2C, F2R | More | | Cyclosporine | hsa05132 | Salmonella infection | 3.99E-04 | 13 | P51617, P01584, P08238, Q96RF0, Q13489, P10415, P08575, O75369, Q13561, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, HSP90AB1, SNAG1, BIRC3, BCL2, PTPRC, FLNB, DCTN2, TUBB3, TUBB2C, VPS41, RAB9B | More | | Cyclosporine | hsa05133 | Pertussis | 5.35E-05 | 6 | P0DP23, P01584, P23528, P09871, P0C0L4, P51617 | CALM1, IL1B, CFL1, C1S, C4A, IRAK1 | More | | Cyclosporine | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Cyclosporine | hsa05135 | Yersinia infection | 1.63E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Cyclosporine | hsa05143 | African trypanosomiasis | 3.87E-02 | 3 | P01584, P17252, P01042 | IL1B, PRKCA, KNG1 | More | | Cyclosporine | hsa05145 | Toxoplasmosis | 5.28E-05 | 9 | P51617, P10415, Q13489, P23458, P42224, P31751, P11142, P29965, Q13651 | IRAK1, BCL2, BIRC3, JAK1, STAT1, AKT2, HSPA8, CD40LG, IL10RA | More | | Cyclosporine | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | | Cyclosporine | hsa05150 | Staphylococcus aureus infection | 1.13E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | | Cyclosporine | hsa05161 | Hepatitis B | 1.31E-04 | 10 | P17252, P18848, P23458, Q13485, P31751, P10415, P27348, P01568, P42224, P51617 | PRKCA, ATF4, JAK1, SMAD4, AKT2, BCL2, YWHAQ, IFNA21, STAT1, IRAK1 | More | | Cyclosporine | hsa05162 | Measles | 2.66E-05 | 12 | P51617, P01568, P23458, P42224, P14784, P42338, P31751, P11142, P01584, Q9NP90, P30279, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, PIK3CB, AKT2, HSPA8, IL1B, RAB9B, CCND2, BCL2 | More | | Cyclosporine | hsa05163 | Human cytomegalovirus infection | 3.30E-05 | 17 | P31751, P42338, P62873, P63218, P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, P17252, Q13651, P18848, P30101, P61769, P01568 | AKT2, PIK3CB, GNB1, GNG5, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, PRKCA, IL10RA, ATF4, PDIA3, B2M, IFNA21 | More | | Cyclosporine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.30E-02 | 4 | P42338, P63218, P19875, P0DP23 | PIK3CB, GNG5, CXCL2, CALM1 | More | | Cyclosporine | hsa05168 | Herpes simplex virus 1 infection | 2.45E-05 | 18 | P01568, P01584, Q9UBU9, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P61769, P31751, Q13398, Q6P280, Q03923, Q9UDV6, P10415, Q14232 | IFNA21, IL1B, NXF1, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, B2M, AKT2, ZNF211, ZNF529, ZNF85, ZNF212, BCL2, EIF2B1 | More | | Cyclosporine | hsa05169 | Epstein-Barr virus infection | 2.76E-02 | 5 | Q13547, P42338, P30101, O75293, P30279 | HDAC1, PIK3CB, PDIA3, GADD45B, CCND2 | More | | Cyclosporine | hsa05170 | Human immunodeficiency virus 1 infection | 4.77E-06 | 16 | P31751, Q02750, P62873, P62879, P16298, P0DP23, P61073, Q05397, P17252, P61769, P01568, P51617, P19174, P23528, P10415, Q9Y6Q5 | AKT2, MAP2K1, GNB1, GNB2, PPP3CB, CALM1, CXCR4, PTK2, PRKCA, B2M, IFNA21, IRAK1, PLCG1, CFL1, BCL2, AP1M2 | More | | Cyclosporine | hsa05200 | Pathways in cancer | 7.38E-12 | 34 | P08514, P42338, P23458, P08238, P42224, P19174, Q15311, P17252, P43246, Q13485, Q13547, P14923, P30279, P10415, Q13489, P49767, P31751, P25116, Q08828, P51828, P62873, P63218, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P16871, P00734, P01042 | ITGA2B, PIK3CB, JAK1, HSP90AB1, STAT1, PLCG1, RALBP1, PRKCA, MSH2, SMAD4, HDAC1, JUP, CCND2, BCL2, BIRC3, VEGFC, AKT2, F2R, ADCY1, ADCY7, GNB1, GNG5, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P68106 | FKBP1B | Peptidyl-prolyl cis-trans isomerase FKBP1B | P08514 | ITGA2B | Integrin alpha-IIb | 0.731 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.761 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | P68106 | FKBP1B | Peptidyl-prolyl cis-trans isomerase FKBP1B | P17252 | PRKCA | Protein kinase C alpha type | 0.733 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.807 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.702 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | Q13547 | HDAC1 | Histone deacetylase 1 | 0.74 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P30279 | CCND2 | G1/S-specific cyclin-D2 | 0.744 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P68106 | FKBP1B | Peptidyl-prolyl cis-trans isomerase FKBP1B | P49767 | VEGFC | Vascular endothelial growth factor C | 0.722 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P68106 | FKBP1B | Peptidyl-prolyl cis-trans isomerase FKBP1B | P25116 | F2R | Proteinase-activated receptor 1 | 0.765 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P68106 | FKBP1B | Peptidyl-prolyl cis-trans isomerase FKBP1B | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.754 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.807 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P68106 | FKBP1B | Peptidyl-prolyl cis-trans isomerase FKBP1B | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.703 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.713 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P0DP23 | CALM1 | Calmodulin-1 | 0.748 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.796 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | P01042 | KNG1 | Kininogen-1 | -0.746 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Cyclosporine | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Cyclosporine | hsa05204 | Chemical carcinogenesis | 2.59E-04 | 4 | P00325, P78417, P11712, P33260 | ADH1B, GSTO1, CYP2C9, CYP2C18 | More | | Cyclosporine | hsa05205 | Proteoglycans in cancer | 4.43E-02 | 3 | Q12955, Q14247, P17252 | ANK3, CTTN, PRKCA | More | | Cyclosporine | hsa05210 | Colorectal cancer | 8.44E-03 | 4 | P42338, Q13485, P43246, O75293 | PIK3CB, SMAD4, MSH2, GADD45B | More | | Cyclosporine | hsa05212 | Pancreatic cancer | 1.66E-04 | 7 | P42338, P31751, Q15311, P23458, P42224, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, STAT1, SMAD4, GADD45B | More | | Cyclosporine | hsa05214 | Glioma | 7.48E-07 | 7 | P0DP23, Q13557, P17252, P42338, P31751, P19174, O75293 | CALM1, CAMK2D, PRKCA, PIK3CB, AKT2, PLCG1, GADD45B | More | | Cyclosporine | hsa05218 | Melanoma | 3.32E-02 | 2 | P42338, O75293 | PIK3CB, GADD45B | More | | Cyclosporine | hsa05220 | Chronic myeloid leukemia | 5.21E-03 | 4 | Q13547, Q13485, P42338, O75293 | HDAC1, SMAD4, PIK3CB, GADD45B | More | | Cyclosporine | hsa05231 | Choline metabolism in cancer | 2.29E-03 | 3 | Q9NRA1, P23743, P17252 | PDGFC, DGKA, PRKCA | More | | Cyclosporine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Cyclosporine | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Cyclosporine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.26E-02 | 1 | P54284 | CACNB3 | More | | Cyclosporine | hsa05415 | Diabetic cardiomyopathy | 4.17E-03 | 5 | P17252, P30405, Q16718, O14521, P37173 | PRKCA, PPIF, NDUFA5, SDHD, TGFBR2 | More | | Cyclosporine | hsa05418 | Fluid shear stress and atherosclerosis | 2.08E-02 | 6 | P14598, P78417, P10415, P0DP23, P08238, Q92974 | NCF1, GSTO1, BCL2, CALM1, HSP90AB1, ARHGEF2 | More | | |